| Affiliation: | 1. Host–Pathogen Interaction Study Group (GEIHP) EA3142, Université d''Angers and Université de Brest, Angers, France;2. Interactions Cellulaires et Applications Thérapeutiques (ICAT), Structure Féderative de Recherche (SFR) 4208, Université d''Angers, Angers, France;3. Université Rennes, Centre Hospitalier Universitaire (CHU) Rennes, Institut National de la Santé et de la Recherche Médicale (INSERM), Ecole des Hautes Études en Santé Publique (EHESP), Institut de Recherche en Santé, Environnement, et Travail (IRSET) Unité Mixte de Recherche (UMR) S1085, Rennes, France;4. Centre de Recherche en Cancérologie et Immunologie Nantes Angers (CRCINA), INSERM, Université de Nantes and Université d''Angers, Angers, France;5. CHU Angers, Département d''Immunologie Allergologie, Angers, France;1. Meyer Cancer Center and Department of Pharmacology, Weill Cornell Medicine, New York, NY 10021, USA;1. Department of Morphology, Surgery, and Experimental Medicine, Section of Pathology, Oncology, and Experimental Biology, Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy;2. Maria Cecilia Hospital, GVM Care and Research, 48033 Cotignola, Ravenna, Italy;1. Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 43210, USA;2. Center for RNA Biology, The Ohio State University, Columbus, OH 43210, USA;3. Ohio State Biochemistry Program, The Ohio State University, Columbus, OH 43210, USA;1. McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, H3A 2B4, Canada;2. Department of Biochemistry, University of Alberta, Edmonton, AB, T6G 2H7, Canada;1. Department of Cellular Biophysics, Max Planck Institute for Medical Research, Stuttgart, Germany;2. Department of Medicine, Division of Hematology/Oncology, University of California at Los Angeles, Los Angeles, CA, USA |
